April 29, 2020 / 7:49 AM / a month ago

BRIEF-Biontech And Pfizer Announce Completion Of Dosing For First Cohort Of Phase 1/2 Trial Of Covid-19 Vaccine Candidates In Germany

April 29 (Reuters) - BioNTech SE, Pfizer Inc :

* ANNOUNCE COMPLETION OF DOSING FOR FIRST COHORT OF PHASE 1/2 TRIAL OF COVID-19 VACCINE CANDIDATES IN GERMANY

* PLAN TO INITIATE TRIALS FOR BNT162 IN UNITED STATES UPON REGULATORY APPROVAL, WHICH IS EXPECTED SHORTLY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below